Menu
FDA · Drug recall

Prasugrel HCI…

Sept. 9, 2026 Class II

Date
Sept. 9, 2026
Risk class
Class II (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote)
Status
Ongoing
Filed by
Golden State Medical Supply Inc.
Product
Prasugrel HCI, Tablets, USP, 10mg, 30-count bottle, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC: 51407-445-30.
Reason
Failed Dissolution Specifications. Notification from the manufacturer that lot is being recalled due to failed dissolution
Distribution pattern
US Nationwide.
Quantity
6791 30-count bottles
Codes and lots
Lot # GS062298, Exp Date: 09/30/ 2026.
Recall started
Aug. 21, 2026
Recall number
D-0847-2026

What should I do? Medicine recall: what to do

Source: FDA · Drug enforcement report, recall number D-0847-2026. The agency record governs; check it and the company before acting.

Report a mistake on this page